Cardiomyopathies aux anthracyclines : détection des patients à risque (résultats de l’observatoire national OFECPACA)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiomyopathies aux anthracyclines : détection des patients à risque (résultats de l’observatoire national OFECPACA)

Published:2022-05 Issue:5 Volume:206 Page:676-683
ISSN:0001-4079
Container-title:Bulletin de l'Académie Nationale de Médecine
language:fr
Short-container-title:Bulletin de l'Académie Nationale de Médecine

Author:

Gibelin P.

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention;Henriksen;Heart,2018

2. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention;Albini;J Natl Cancer Inst,2010

3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur J Heart Fail,2017

4. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography;Schwartz;Am J Med,1987

5. Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer;Nielsen;J Clin Oncol,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3